Skip to main content

Binary Subclassification Scheme (AUS-Nuclear versus AUS-Other) Adequately Risk-Stratifies Thyroid Fine Needle Aspiration Spec

Tracking # 20-1281240

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

The eJournal is an online pathology journal club that reviews current articles from a peer-reviewed cytopathology Journal. Participants will be able to review the journal article, commentary and webinar from the contributing author. This is a great self-assessment, teaching and continuing education tool. Target Audience This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community. Learning Objectives To understand the role of nuclear atypia in determining the risk of malignancy in AUS thyroid nodules To assess the clinical impact of molecular testing in managing AUS thyroid nodules To discuss the potential benefits of adopting a binary subclassification scheme for AUS thyroid nodules in clinical practice Presenter(s): Seyedreza Mousavi MD, MS, CT(ASCP), MB, CT(IAC) Michiya Nishino, MD, PhD

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

1h General (Cytology)

Clinical Laboratory Supervisor

1h General (Cytology)

Clinical Laboratory Technician

1h General (Cytology)

Clinical Laboratory Technologist

1h General (Cytology)

Public Health Director

1h General (Cytology)

Public Health Supervisor

1h General (Cytology)

Public Health Technologist

1h General (Cytology)

Disclosure statements

The presenters have no conflicts of interest or financial relationships to disclose.